Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2017
Nov. 30, 2016
Nov. 30, 2017
Nov. 30, 2016
Condensed Consolidated Statements Of Operations And Comprehensive Loss        
Revenue
Operating Expenses -        
Research and development 3,894,454 368,403 5,341,763 1,217,600
General and administrative 2,720,078 277,951 4,691,294 1,034,007
Depreciation and amortization 98,755 102,244 281,016 290,396
Foreign exchange loss (gain) (9,634) 809 88,634 (2,880)
Total operating expenses 6,703,653 749,407 10,402,707 2,539,123
Net Loss (6,703,653) (749,407) (10,402,707) (2,539,123)
Other comprehensive gain (loss) -        
Foreign currency translation adjustment 155,354 (18,488) (2,068) (42,846)
Comprehensive Loss $ (6,548,299) $ (767,895) $ (10,404,775) $ (2,581,969)
Loss per share- Basic and Diluted $ (0.20) $ (0.02) $ (0.32) $ (0.08)
Weighted average common shares outstanding- Basic and Diluted 32,793,181 31,390,807 32,183,343 31,001,702